The Challenge of Change - Managing Excipients Control
Colorcon
20-Sep-2004 - The world's leading pharmaceutical companies are not doing enough to help improve the health of countries in the third world. They will also be completely unprepared to face the increasing demand for drugs for diseases other than Aids.
16-Sep-2004 - The Generic Pharmaceutical Association (GPhA) has urged the US Food and Drug Administration (FDA) to move forward to accelerate the approval of affordable generic versions of biopharmaceutical drugs.
16-Sep-2004 - Rumours of the demise of Ireland as a hotbed of pharmaceutical manufacturing may be premature. Pfizer has just unveiled a plan to spend €240 million to expand its Dun Laoghaire plant in Dublin.
15-Sep-2004 - LGC, the independent analytical laboratory, has set up an initiative alongside the UK Chemical Industries Association (CIA) to advise chemical companies how to handle the new REACH legislation.
14-Sep-2004 - A groundbreaking new treatment for psoriasis could be available to patients in Europe as early as next month, providing the European Medicines Agency (EMEA) follows the advice of its advisory committee.
13-Sep-2004 - Bayer has continued the sweeping reforms across its business with the creation of a broad pharmaceuticals alliance with US drugmaker Schering-Plough.
13-Sep-2004 - US life science company Serologicals has entered into a €167.6 million merger with cell signallin specialist Upstate, creating a significant presence in the preclinical drug screening and target validation market, the fastest growing segment of the life sciences tools industry.
13-Sep-2004 - Biotechnology Company, Nucleonics, has filed a request with the Commissioner of Patents in Australia for Re-Examination, which questions the validity of Benitec's patent concerning gene-silencing technology claiming ambiguity and lack adequate support in the specification.
08-Sep-2004 - The pharmaceutical industry has announced it would introduce a central, accessible database to improve the communication of the clinical study results of marketed drugs.
08-Sep-2004 - The latest study to lament the cost of implementing the European Union's REACH system has predicted dire consequences for the EU's Gross Domestic Product, production base and innovative strength.
08-Sep-2004 - The US Food and Drug Administration has failed to reach a decision on approving a growth hormone (hGH) product developed by Novartis' generics subsidiary Sandoz in what is emerging as a test case for the development of generic copies of biological drugs.
08-Sep-2004 - GlaxoSmithKline are to commission the pharmaceutical industry's first in-house Accelerator Mass Spectrometry (AMS) facility, with the primary aim of providing information on human metabolite formation of new drug candidates and detail pathways of drug metabolism.
07-Sep-2004 - China has defended its decision to overturn Pfizer's patent on its blockbuster drug for erectile dysfunction, Viagra (sildenafil), in a ruling that was seen as a blow to hopes that the country would enforce intellectual property rights.
06-Sep-2004 - The cumulative effect of patients failing to adhere to their treatment regimens is costing the pharmaceutical industry in excess of $30 billion a year, says a new report from Datamonitor which proffers some solutions to the problem.
06-Sep-2004 - The number one drugmaker - Pfizer - has stepped up its legal campaign against the trade in counterfeit versions of its top-selling drug Lipitor (atorvastatin), one of the most copied drugs on the market.
02-Sep-2004 - After two difficult years, there are more signals in 2004 that trends are turning in the economic situation of German biotechnology companies, according to Prof Peter Stadler, chairman of the German Association of Biotechnology Industries (DIB).
01-Sep-2004 - A new approach to treating obesity which blocks brain signals that control cravings has shown promising results in human subjects during advanced clinical trials paving the way for further testing and an eventual launch date.
01-Sep-2004 - A team of researchers has issued a plea that that microarray-derived gene expression data should be available in a public repository in the same way that gene sequence data is collated for use by all.
31-Aug-2004 - The US Food and Drug Administration has stepped up its activities in combating drug counterfeiting by bringing charges against drug wholesalers for failing to carry out measures designed to safeguard the pharmaceutical supply chain.
27-Aug-2004 - GlaxoSmithKline (GSK) became the first major drug maker to disclose details of its clinical drug trials effectively settling a lawsuit filed by the New York state attorney general, Eliot Spitzer, who accused them of concealing information about the harmful effects of its antidepressant on children.
27-Aug-2004 - UK-based Lock Inspection Systems, a leading manufacturer of weighing and metal detection system, has announced the opening of a regional commercial office for Asia-Pacific to meet with growing demand for its products across the region.
25-Aug-2004 - The emergence of cases of mad cow disease in North America has not raised any public health concern from animal-derived medicinal materials such as bovine blood derivatives and gelatin.
23-Aug-2004 - French pharmaceutical group Sanofi-Synthelabo on Friday formally announced the birth of Sanofi-Aventis, the world's third-largest pharmaceutical company, ranking number one in Europe.
20-Aug-2004 - In an open letter to the British medical Journal, the director of the UK Cochrane Centre Sir Iain Chalmers has added his voice to those calling for complete disclosure of clinical trials by pharmaceutical companies.
19-Aug-2004 - Companies from Europe, the US and Japan have announced the construction of new facilities this month, suggesting that despite a difficult operating environment big pharma is still making significant capital investments.